These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 23884541)
1. Osteopontin and adiponectin: how far are they related in the complexity of psoriasis? Kadry D; Hegazy RA; Rashed L Arch Dermatol Res; 2013 Dec; 305(10):939-44. PubMed ID: 23884541 [TBL] [Abstract][Full Text] [Related]
2. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. Chen YJ; Shen JL; Wu CY; Chang YT; Chen CM; Lee FY J Am Acad Dermatol; 2009 Feb; 60(2):225-30. PubMed ID: 19028408 [TBL] [Abstract][Full Text] [Related]
3. The relationship between osteopontin and adiponectin in patients with essential hypertension. Kurata M; Okura T; Irita J; Enomoto D; Nagao T; Jotoku M; Miyoshi K; Higaki J Clin Exp Hypertens; 2010; 32(6):358-63. PubMed ID: 21028999 [TBL] [Abstract][Full Text] [Related]
4. Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis. Kadry D; Rashed L J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):66-70. PubMed ID: 21366712 [TBL] [Abstract][Full Text] [Related]
5. Osteopontin, CCL5 and CXCL9 are independently associated with psoriasis, regardless of the presence of obesity. Duarte GV; Boeira V; Correia T; Porto-Silva L; Cardoso T; Macedo MN; Oliveira MF; Carvalho E Cytokine; 2015 Aug; 74(2):287-92. PubMed ID: 25972108 [TBL] [Abstract][Full Text] [Related]
6. Assessment of serum levels of osteopontin, selenium and prolactin in patients with psoriasis compared with healthy controls, and their association with psoriasis severity. Toossi P; Sadat Amini SH; Sadat Amini MS; Partovi Kia M; Enamzade R; Kazeminejad A; Esmaeily Radvar S; Younespour S Clin Exp Dermatol; 2015 Oct; 40(7):741-6. PubMed ID: 25991399 [TBL] [Abstract][Full Text] [Related]
7. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Hung J; McQuillan BM; Thompson PL; Beilby JP Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163 [TBL] [Abstract][Full Text] [Related]
8. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Eder L; Jayakar J; Pollock R; Pellett F; Thavaneswaran A; Chandran V; Rosen CF; Gladman DD Ann Rheum Dis; 2013 Dec; 72(12):1956-61. PubMed ID: 23243196 [TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men. Onat A; Hergenç G; Can G; Küçükdurmaz Z Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels. da Silva TF; Levy-Neto M; Bonfá E; Pereira RM J Rheumatol; 2013 Nov; 40(11):1897-904. PubMed ID: 24037555 [TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337 [TBL] [Abstract][Full Text] [Related]
12. Serum osteopontin concentration is decreased by exercise-induced fat loss but is not correlated with body fat percentage in obese humans. You JS; Ji HI; Chang KJ; Yoo MC; Yang HI; Jeong IK; Kim KS Mol Med Rep; 2013 Aug; 8(2):579-84. PubMed ID: 23764959 [TBL] [Abstract][Full Text] [Related]
13. Serum concentration of osteopontin and interleukin 17 in psoriatic patients. Przepiórka-Kosińska JM; Bartosińska J; Raczkiewicz D; Bojar I; Kosiński J; Krasowska D; Chodorowska G Adv Clin Exp Med; 2020 Feb; 29(2):203-208. PubMed ID: 32109010 [TBL] [Abstract][Full Text] [Related]
14. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284 [TBL] [Abstract][Full Text] [Related]
16. Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy. Buommino E; De Filippis A; Gaudiello F; Balato A; Balato N; Tufano MA; Ayala F Arch Dermatol Res; 2012 Aug; 304(6):481-5. PubMed ID: 22684781 [TBL] [Abstract][Full Text] [Related]
17. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Calcaterra V; De Amici M; Klersy C; Torre C; Brizzi V; Scaglia F; Albanesi M; Albertini R; Allais B; Larizza D Acta Biomed; 2009 Aug; 80(2):117-23. PubMed ID: 19848048 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C. Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135 [TBL] [Abstract][Full Text] [Related]
20. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]